Cooper Investors Global Equities Fund sold its stake in GE Healthcare (GEHC). here’s why

Cooper Investors Global Equities Fund sold its stake in GE Healthcare (GEHC). here’s why
Cooper Investors Global Equities Fund sold its stake in GE Healthcare (GEHC). here’s why

Cooper Investors, an investment management firm, released its Q3 2025 investor letter “Cooper Investors Global Equities Fund (Unhedged).” A copy of the letter can be downloaded here. The fund returned -0.04% in the third quarter, compared to a return of 6.42% for the MSCI AC World Index Net Divs in Australian dollars. However, the fund earned an annual return of 18.0% in subsequent fees. Since the portfolio structure is not primarily correlated with the index, its returns should not vary in line with the index. Plus, check out the fund’s top five holdings to learn your best picks in 2025.

In its Q3 2025 investor letter, Cooper Investors Global Equities Fund highlighted stocks like GE HealthCare Technologies Inc. (NASDAQ:GEHC). GE HealthCare Technologies Inc. (NASDAQ:GEHC) manufactures and markets complementary digital products, services and solutions used in the diagnosis, treatment and monitoring of patients. GE HealthCare Technologies Inc. (NASDAQ:GEHC)’s monthly performance was 16.30% and its shares gained 4.35% of its value in the last 52 weeks. On December 5, 2025, GE HealthCare Technologies Inc. (NASDAQ:GEHC) stock closed at $85.46 per share, with a market capitalization of $39.018 million.

Cooper Investors Global Equities Fund stated the following regarding GE HealthCare Technologies Inc. (NASDAQ:GEHC) in its Q3 2025 investor letter:

“GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a US-based medical device company that was added to the portfolio in late 2023. The company’s core products are large, sophisticated imaging machines (ultrasound, X-ray, CT scanners, etc.). GEHC was spun off from GE in early 2023, setting the business up to benefit from a classic “targeted dividend”: a dedicated management team in charge of capital allocation and strategy now able to drive value creation from a pool of assets that had not been optimized within a large organization like GE.

Was Jim Cramer Right About GE Healthcare Technologies Inc. (GEHC)?
Was Jim Cramer Right About GE Healthcare Technologies Inc. (GEHC)?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) isn’t on our list of the 30 most popular stocks among hedge funds. According to our database, 58 hedge fund portfolios owned GE HealthCare Technologies Inc. (NASDAQ:GEHC) at the end of the third quarter, up from 72 in the previous quarter. In the third quarter of 2025, GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported revenue of $5.1 billion, up 4% organically, beating expectations. While we recognize the potential of GE HealthCare Technologies Inc. (NASDAQ:GEHC) as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.

In another article, we covered GE HealthCare Technologies Inc. (NASDAQ:GEHC) and shared the list of the best digital health stocks to buy. Also, see our Q3 2025 Letters to Hedge Fund Investors page for more letters to hedge fund investors and other leading investors.

READ NEXT: The best and worst Dow stocks for the next 12 months and 10 unstoppable stocks that could double your money.

Disclosure: None. This article was originally published on Insider Monkey.

Source link